| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3254417 | Best Practice & Research Clinical Gastroenterology | 2015 | 15 Pages |
Abstract
Increasing incidence of oesophageal adenocarcinoma along with poor survival entails novel preventive strategies. Agents that target pro-oncogenic pathways in Barrett's mucosa could halt this neoplastic transformation. In this review, we will use epidemiological associations and molecular mechanisms to identify novel chemoprevention targets in Barrett's oesophagus. We will also discuss recent chemoprevention trials.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Anushka Baruah, Navtej S. Buttar,